Analyst Ratings for Gemphire Therapeutics (GEMP)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/27/2019 | Laidlaw | N/A | Upgrade | Buy (Hold) |
N/A (N/A) |
1.20 (0.30) |
-75% | Details |
8/13/2018 | Jefferies | Matthew Andrews | Downgrade | Hold (Buy) |
2.00 (12.00) |
3.27 (0.30) |
-90.83% | Details |